Chicago Partners Investment Group LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1563525
CHICAGO, IL
Position in REGN
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$1,546,052
+$507,887 QoQ
Shares Held
2,001
+48.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
5 quarters on record
Voting authority
Sole 7.546226886556721.ToString("F0")%
Shared 0.ToString("F0")%
None 92.45377311344328.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Chicago Partners Investment Group LLC holds $9,972,920 across 37 Biotechnology names. REGN ranks #1 (15.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,001 | $1,546,052 | |
| 2 | INCY |
Incyte Corp
|
8,174 | $769,336 | |
| 3 | TSHA |
Taysha Gene Therapies, Inc.
|
170,751 | $763,256 | |
| 4 | ASND |
Ascendis Pharma A/S
|
3,054 | $698,541 | |
| 5 | EXEL |
Exelixis, Inc.
|
16,204 | $694,989 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
12,183 | $688,217 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
2,861 | $540,872 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,170 | $522,451 |
All Filings in REGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,546,052 | 2,001 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,038,165 | 1,345 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $531,345 | 945 | Shares | Sole | 2025-10-30 | |
| 2021-09-30 | $219,075 | 362 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $270,040 | 433 | Shares | Sole | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||